American Shared Hospital Services (AMS)
3.044
-0.21
(-6.32%)
USD |
NYAM |
Apr 30, 16:00
3.11
+0.07
(+2.15%)
After-Hours: 20:00
American Shared Hospital Services Enterprise Value: 26.82M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 26.82M |
| April 29, 2024 | 28.12M |
| April 26, 2024 | 27.62M |
| April 25, 2024 | 27.30M |
| April 24, 2024 | 26.67M |
| April 23, 2024 | 26.51M |
| April 22, 2024 | 26.60M |
| April 19, 2024 | 26.48M |
| April 18, 2024 | 25.97M |
| April 17, 2024 | 26.48M |
| April 16, 2024 | 26.22M |
| April 15, 2024 | 25.72M |
| April 12, 2024 | 26.10M |
| April 11, 2024 | 26.22M |
| April 10, 2024 | 26.07M |
| April 09, 2024 | 26.35M |
| April 08, 2024 | 26.35M |
| April 05, 2024 | 26.10M |
| April 04, 2024 | 26.16M |
| April 03, 2024 | 26.04M |
| April 02, 2024 | 26.10M |
| April 01, 2024 | 26.10M |
| March 28, 2024 | 26.22M |
| March 27, 2024 | 24.58M |
| March 26, 2024 | 23.95M |
| Date | Value |
|---|---|
| March 25, 2024 | 23.91M |
| March 22, 2024 | 24.26M |
| March 21, 2024 | 24.44M |
| March 20, 2024 | 24.31M |
| March 19, 2024 | 23.68M |
| March 18, 2024 | 23.74M |
| March 15, 2024 | 23.74M |
| March 14, 2024 | 24.28M |
| March 13, 2024 | 24.18M |
| March 12, 2024 | 23.99M |
| March 11, 2024 | 24.50M |
| March 08, 2024 | 24.80M |
| March 07, 2024 | 24.52M |
| March 06, 2024 | 24.56M |
| March 05, 2024 | 24.56M |
| March 04, 2024 | 24.56M |
| March 01, 2024 | 24.56M |
| February 29, 2024 | 24.62M |
| February 28, 2024 | 24.69M |
| February 27, 2024 | 24.88M |
| February 26, 2024 | 24.88M |
| February 23, 2024 | 24.50M |
| February 22, 2024 | 24.81M |
| February 21, 2024 | 24.44M |
| February 20, 2024 | 24.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.96M
Minimum
Apr 03 2020
36.51M
Maximum
May 06 2021
23.04M
Average
23.35M
Median
Nov 09 2022
Enterprise Value Benchmarks
| Novo Integrated Sciences Inc | 13.96M |
| Astrana Health Inc | 1.444B |
| Cryo-Cell International Inc | 76.90M |
| P3 Health Partners Inc | 427.64M |
| Biote Corp | 215.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.415M |
| Revenue (Quarterly) | 5.698M |
| Total Expenses (Quarterly) | 4.642M |
| EPS Diluted (Quarterly) | 0.06 |
| Gross Profit Margin (Quarterly) | 49.42% |
| Profit Margin (Quarterly) | 7.28% |
| Earnings Yield | 2.96% |
| Operating Earnings Yield | 11.89% |
| Normalized Earnings Yield | 6.920 |